163 related articles for article (PubMed ID: 32087559)
1. Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.
Wu W; Wu Y; Mayer K; von Rosenstiel C; Schecker J; Baur S; Würstle S; Liesche-Starnecker F; Gempt J; Schlegel J
Transl Oncol; 2020 Mar; 13(3):100748. PubMed ID: 32087559
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells.
Wu Y; Franzmeier S; Liesche-Starnecker F; Schlegel J
Cells; 2023 Oct; 12(21):. PubMed ID: 37947601
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1A3 (ALDH1A3) is regulated by autophagy in human glioblastoma cells.
Wu W; Schecker J; Würstle S; Schneider F; Schönfelder M; Schlegel J
Cancer Lett; 2018 Mar; 417():112-123. PubMed ID: 29306018
[TBL] [Abstract][Full Text] [Related]
4. EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.
Shi ZF; Li GZ; Zhai Y; Pan CQ; Wang D; Yu MC; Liu C; Zhang W; Yu XG
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980923
[TBL] [Abstract][Full Text] [Related]
5. ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis.
Wu Y; Kram H; Gempt J; Liesche-Starnecker F; Wu W; Schlegel J
Cells; 2022 Dec; 11(24):. PubMed ID: 36552781
[TBL] [Abstract][Full Text] [Related]
6. ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.
Li G; Li Y; Liu X; Wang Z; Zhang C; Wu F; Jiang H; Zhang W; Bao Z; Wang Y; Cai J; Zhao L; Kahlert UD; Jiang T; Zhang W
Cell Death Dis; 2018 Dec; 9(12):1190. PubMed ID: 30538217
[TBL] [Abstract][Full Text] [Related]
7. Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line.
Weidemann H; Feger D; Ehlert JE; Menger MM; Krempien RC
Discov Oncol; 2023 Feb; 14(1):27. PubMed ID: 36840822
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
[TBL] [Abstract][Full Text] [Related]
9. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
10. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
[TBL] [Abstract][Full Text] [Related]
11. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
[TBL] [Abstract][Full Text] [Related]
12. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
13. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
15. A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.
Wen YT; Wu AT; Bamodu OA; Wei L; Lin CM; Yen Y; Chao TY; Mukhopadhyay D; Hsiao M; Huang HS
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561595
[TBL] [Abstract][Full Text] [Related]
16. Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.
Valtorta S; Lo Dico A; Raccagni I; Gaglio D; Belloli S; Politi LS; Martelli C; Diceglie C; Bonanomi M; Ercoli G; Vaira V; Ottobrini L; Moresco RM
Oncotarget; 2017 Dec; 8(68):113090-113104. PubMed ID: 29348889
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
19. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
[TBL] [Abstract][Full Text] [Related]
20. Cold Atmospheric Plasma Increases Temozolomide Sensitivity of Three-Dimensional Glioblastoma Spheroids via Oxidative Stress-Mediated DNA Damage.
Shaw P; Kumar N; Privat-Maldonado A; Smits E; Bogaerts A
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
